电动轮椅市场－全球产业规模、份额、趋势、机会和预测，按类别（成人、儿童）、最终用途（医院、门诊机构、家庭护理）、地区和竞争格局划分，2020-2030年预测

2024年全球电动轮椅市场规模为39.8亿美元，预计2030年将以9.26%的复合年增长率成长至67.7亿美元。电动轮椅是一种由电动马达和电池驱动的专用行动辅助设备，旨在为行动不便的人士提供独立出行的能力。推动全球电动轮椅市场成长的主要因素包括：全球人口老化、慢性疾病和残疾盛行率上升，以及不断提升电动轮椅功能和使用者体验的技术进步。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球电动轮椅市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类别（成人、儿童）
  • 依最终用途（医院、门诊机构、家庭护理）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美电动轮椅市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲电动轮椅市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区电动轮椅市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东与非洲电动轮椅市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲电动轮椅市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球电动轮椅市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.
• CSL Behring LLC
• Attune Pharmaceuticals, Inc.
• Adverum Biotechnologies, Inc.
• KalVista Pharmaceuticals, Inc.
• Takeda Pharmaceutical Company Limited
• Pharming Group NV
• Sanofi SA
• Cipla Limited

第十六章：策略建议

第17章调查会社について・免责事项

The Global Electric Wheelchair Market, valued at USD 3.98 Billion in 2024, is projected to experience a CAGR of 9.26% to reach USD 6.77 Billion by 2030. An electric wheelchair is a specialized mobility device propelled by an electric motor and battery, designed to provide independent locomotion for individuals with limited physical mobility. The global market for these devices is primarily driven by an aging worldwide population, a rising prevalence of chronic diseases and disabilities, and continuous technological advancements improving functionality and user experience.

Key Market Drivers

The increasing global aging population significantly fuels demand within the electric wheelchair market. As individuals live longer, the likelihood of age-related conditions that impair mobility naturally rises, directly increasing the need for assistive devices that restore independence. According to United Nations population projections, in June 2024, the worldwide share of people aged 65 almost doubled from 5.5 percent to 10.3 percent between 1974 and 2024, illustrating a substantial demographic shift towards an older population. This demographic change necessitates a greater supply of electric wheelchairs to support daily activities for a growing segment of consumers facing mobility challenges.

Key Market Challenges

The substantial initial acquisition cost of electric wheelchairs represents a significant impediment to the expansion of the global market. This financial barrier directly limits market penetration by making these essential mobility devices inaccessible to a considerable portion of the target demographic. The high upfront investment required for electric wheelchairs poses a substantial hurdle for many potential users, particularly in regions with limited healthcare reimbursement programs or lower average disposable incomes.

Key Market Trends

The market for electric wheelchairs is being significantly shaped by the enhanced portability offered through lightweight and foldable designs. This trend addresses a crucial user need for greater convenience, ease of transport, and storage, thereby expanding the accessibility and utility of these devices in daily life and travel. Such designs enable users and caregivers to more easily manage the device for vehicle transfers, public transportation, or compact living spaces. For example, Sunrise Medical introduced the QUICKIE Q50 R Carbon in March 2024, its lightest folding power wheelchair with a transport weight of only 32 lbs, directly reflecting this emphasis on portability.

Key Market Players

• BioCryst Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.
• CSL Behring LLC
• Attune Pharmaceuticals, Inc.
• Adverum Biotechnologies, Inc.
• KalVista Pharmaceuticals, Inc.
• Takeda Pharmaceutical Company Limited
• Pharming Group N.V.
• Sanofi S.A.
• Cipla Limited

Report Scope:

In this report, the Global Electric Wheelchair Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Electric Wheelchair Market, By Category:

• Adult
• Pediatric

Electric Wheelchair Market, By End-use:

• Hospitals
• Outpatient Facilities
• Homecare

Electric Wheelchair Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Electric Wheelchair Market.

Available Customizations:

Global Electric Wheelchair Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Electric Wheelchair Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Category (Adult, Pediatric)
  • 5.2.2. By End-use (Hospitals, Outpatient Facilities, Homecare)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Electric Wheelchair Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Category
  • 6.2.2. By End-use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Electric Wheelchair Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Category
      • 6.3.1.2.2. By End-use
  • 6.3.2. Canada Electric Wheelchair Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Category
      • 6.3.2.2.2. By End-use
  • 6.3.3. Mexico Electric Wheelchair Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Category
      • 6.3.3.2.2. By End-use

7. Europe Electric Wheelchair Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Category
  • 7.2.2. By End-use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Electric Wheelchair Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Category
      • 7.3.1.2.2. By End-use
  • 7.3.2. France Electric Wheelchair Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Category
      • 7.3.2.2.2. By End-use
  • 7.3.3. United Kingdom Electric Wheelchair Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Category
      • 7.3.3.2.2. By End-use
  • 7.3.4. Italy Electric Wheelchair Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Category
      • 7.3.4.2.2. By End-use
  • 7.3.5. Spain Electric Wheelchair Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Category
      • 7.3.5.2.2. By End-use

8. Asia Pacific Electric Wheelchair Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Category
  • 8.2.2. By End-use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Electric Wheelchair Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Category
      • 8.3.1.2.2. By End-use
  • 8.3.2. India Electric Wheelchair Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Category
      • 8.3.2.2.2. By End-use
  • 8.3.3. Japan Electric Wheelchair Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Category
      • 8.3.3.2.2. By End-use
  • 8.3.4. South Korea Electric Wheelchair Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Category
      • 8.3.4.2.2. By End-use
  • 8.3.5. Australia Electric Wheelchair Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Category
      • 8.3.5.2.2. By End-use

9. Middle East & Africa Electric Wheelchair Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Category
  • 9.2.2. By End-use
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Electric Wheelchair Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Category
      • 9.3.1.2.2. By End-use
  • 9.3.2. UAE Electric Wheelchair Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Category
      • 9.3.2.2.2. By End-use
  • 9.3.3. South Africa Electric Wheelchair Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Category
      • 9.3.3.2.2. By End-use

10. South America Electric Wheelchair Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Category
  • 10.2.2. By End-use
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Electric Wheelchair Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Category
      • 10.3.1.2.2. By End-use
  • 10.3.2. Colombia Electric Wheelchair Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Category
      • 10.3.2.2.2. By End-use
  • 10.3.3. Argentina Electric Wheelchair Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Category
      • 10.3.3.2.2. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Electric Wheelchair Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. BioCryst Pharmaceuticals, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Ionis Pharmaceuticals, Inc.
• 15.3. CSL Behring LLC
• 15.4. Attune Pharmaceuticals, Inc.
• 15.5. Adverum Biotechnologies, Inc.
• 15.6. KalVista Pharmaceuticals, Inc.
• 15.7. Takeda Pharmaceutical Company Limited
• 15.8. Pharming Group N.V.
• 15.9. Sanofi S.A.
• 15.10. Cipla Limited

16. Strategic Recommendations

17. About Us & Disclaimer